Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer.

Curr Oncol · 2021 · PMC8534510 · PMID 34677243

Europe PMC DOI

hedged sentence

0.1734

closest p · 3.5× alpha

0.1734

boldest claim

The sentences

did not reach statistical significancep = 0.1734not close (p > 0.1)

The difference in mOS between 2L IT and 2L NT was significant (HR: 0.454, p = 0.0047), but 2L CT to 2L NT comparison did not reach statistical significance (HR: 0.639, p = 0.1734).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.